Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 GBX | -0.88% | +3.73% | +56.50% |
May. 08 | Home REIT cuts borrowings, Genflow shares restored | AN |
May. 08 | Genflow Biosciences Resumes London Trading | MT |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 7.02 | 4.168 |
Enterprise Value (EV) 1 | 4.664 | 3.484 |
P/E ratio | -5.26 x | -2.56 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | -3,494,070 x | -2,140,632 x |
EV / FCF | -4,952,642 x | -3,318,341 x |
FCF Yield | -0% | -0% |
Price to Book | 2.97 x | 5.74 x |
Nbr of stocks (in thousands) | 292,507 | 292,507 |
Reference price 2 | 0.0240 | 0.0142 |
Announcement Date | 6/8/23 | 5/7/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | -1.335 | -1.628 |
EBIT 1 | -0.6499 | -1.335 | -1.629 |
Operating Margin | - | - | - |
Earnings before Tax (EBT) 1 | -0.651 | -1.335 | -1.629 |
Net income 1 | -0.651 | -1.335 | -1.629 |
Net margin | - | - | - |
EPS 2 | -0.8177 | -0.004565 | -0.005570 |
Free Cash Flow | - | -0.9417 | -1.05 |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 1/7/22 | 6/8/23 | 5/7/24 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | - | - | - |
Net Cash position 1 | 0.25 | 2.36 | 0.68 |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | -0.94 | -1.05 |
ROE (net income / shareholders' equity) | - | -110% | -105% |
ROA (Net income/ Total Assets) | - | -57.7% | -55.2% |
Assets 1 | - | 2.316 | 2.951 |
Book Value Per Share 2 | 0.0300 | 0.0100 | 0 |
Cash Flow per Share 2 | 0.0400 | 0.0100 | 0 |
Capex | - | 0 | 0 |
Capex / Sales | - | - | - |
Announcement Date | 1/7/22 | 6/8/23 | 5/7/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+56.50% | 10.01M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.64% | 21.97B | |
-4.69% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- GENF Stock
- Financials Genflow Biosciences plc